This is our continuation for Part 2 of this weeks episode where we have updates for you from the FDA for approval of Tabrecta for non small cell lung cancer and approval of Farxiga as a stand alone agent for the treatment of heart failure in adults. We'll also be giving our regular update on coronavirus numbers to date. Feel free to like, share, and subscribe. Enjoy!